Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 20, 2019 - Issue 3-4
Submit an article Journal homepage
538
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Early post-marketing experience with edaravone in an unselected group of patients with ALS

Alon AbrahamDepartment of Neurology, Neuromuscular Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, ;Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel, Correspondence[email protected]
,
Beatrice NefussyDepartment of Neurology, Neuromuscular Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel,
,
Yaara FainmesserDepartment of Neurology, Neuromuscular Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel,
,
Yoram EbrahimiSackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel,
,
Arnon KarniSackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel, ;Neuroimmunology Unit, Tel Aviv Sourasky Medical Center, Segol School of Neuroscience, Tel Aviv University, Tel-Aviv, Israel
&
Vivian E. DroryDepartment of Neurology, Neuromuscular Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, ;Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel,
Pages 260-263 | Received 14 Oct 2018, Accepted 12 Jan 2019, Published online: 20 Feb 2019

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

R Hergesheimer, D Lanznaster, P Vourc’h, Cr Andres, Se Bakkouche, S Beltran, H Blasco, P Corcia & P Couratier. (2020) Advances in disease-modifying pharmacotherapies for the treatment of amyotrophic lateral sclerosis. Expert Opinion on Pharmacotherapy 21:9, pages 1103-1110.
Read now

Articles from other publishers (14)

Du Hong, Chi Zhang, Wenshuo Wu, Xiaohui Lu & Liping Zhang. (2023) Modulation of the gut–brain axis via the gut microbiota: a new era in treatment of amyotrophic lateral sclerosis. Frontiers in Neurology 14.
Crossref
Angela Genge, Benjamin Rix Brooks, Björn Oskarsson, Alexander Kalin, Ming Ji, Stephen Apple & Laura Bower. (2022) Analysis of the US Safety Data for Edaravone (Radicava®) From the Third Year After Launch. Drugs in R&D 22:3, pages 205-211.
Crossref
Maleesha Jayasinghe, Rahul Jena, Malay Singhal, Samiksha Jain, Snigdha Karnakoti, Minollie Suzanne Silva & Abdul Mueez Alam Kayani. (2022) Ethnical Disparities in Response to Edaravone in Patients With Amyotrophic Lateral Sclerosis. Cureus.
Crossref
Simon Witzel, André Maier, Robert Steinbach, Julian Grosskreutz, Jan C. Koch, Anastasia Sarikidi, Susanne Petri, René Günther, Joachim Wolf, Andreas Hermann, Johannes Prudlo, Isabell Cordts, Paul Lingor, Wolfgang N. Löscher, Zacharias Kohl, Tim Hagenacker, Christian Ruckes, Birgit Koch, Susanne Spittel, Kornelia Günther, Sebastian Michels, Johannes Dorst, Thomas Meyer & Albert C. Ludolph. (2022) Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral Sclerosis. JAMA Neurology 79:2, pages 121.
Crossref
Elise Liu, Léa Karpf & Delphine Bohl. (2021) Neuroinflammation in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia and the Interest of Induced Pluripotent Stem Cells to Study Immune Cells Interactions With Neurons. Frontiers in Molecular Neuroscience 14.
Crossref
C. Quarracino, M. Bendersky, R. Rey & G. E. Rodríguez. (2020) Logistics and safety of edaravone treatment for amyotrophic lateral sclerosis: experience in Argentina. Acta Neurologica Belgica 121:6, pages 1519-1523.
Crossref
Gary W. Gallagher, Dustin Nowacek, Olivia Gutgsell & Brian C. Callaghan. (2021) Comparison of the United Kingdom and United States approaches to approval of new neuromuscular therapies. Muscle & Nerve 64:6, pages 641-650.
Crossref
Eugenio Distaso, Giammarco Milella, Domenico Maria Mezzapesa, Alessandro Introna, Eustachio D’Errico, Angela Fraddosio, Stefano Zoccolella, Franca Dicuonzo & Isabella Laura Simone. (2021) Magnetic resonance metrics to evaluate the effect of therapy in amyotrophic lateral sclerosis: the experience with edaravone. Journal of Neurology 268:9, pages 3307-3315.
Crossref
Alizée Arnoux & Luc Dupuis. 2021. 5-HT2B Receptors. 5-HT2B Receptors 367 386 .
Juan Fernando Ortiz, Sawleha Arshi Khan, Amr Salem, Zayar Lin, Zafar Iqbal & Nusrat Jahan. (2020) Post-Marketing Experience of Edaravone in Amyotrophic Lateral Sclerosis: A Clinical Perspective and Comparison With the Clinical Trials of the Drug. Cureus.
Crossref
Michelle Vu, Kathryn Tortorice, Jennifer Zacher, Diane Dong, Kwan Hur, Rongping Zhang, Chester B. Good, Peter A. Glassman & Francesca E. Cunningham. (2020) Assessment of Use and Safety of Edaravone for Amyotrophic Lateral Sclerosis in the Veterans Affairs Health Care System. JAMA Network Open 3:10, pages e2014645.
Crossref
Snežana Spasić, Aleksandra Nikolić-Kokić, Srđan Miletić, Zorana Oreščanin-Dušić, Mihajlo B. Spasić, Duško Blagojević & Zorica Stević. (2020) Edaravone May Prevent Ferroptosis in ALS. Current Drug Targets 21:8, pages 776-780.
Crossref
Łukasz Puchała, Stanisław Maksymowicz, Tomasz Siwek & Marcin P. Mycko. (2020) Edaravone, a new therapeutic option in amyotrophic lateral sclerosis: Evaluation of challenges in the drug accessibility. Polish Annals of Medicine.
Crossref
Natalia Nowicka, Jakub Juranek, Judyta K. Juranek & Joanna Wojtkiewicz. (2019) Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 20:11, pages 2616.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.